ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Zai Lab Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$24.06+0.87 (+3.75%)
Close on Oct 19, 2026
- Market cap
- $26.87B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
10.1%
43M of 430M shares
Institutional holders
93
16 new, 21 sold out
Net institutional buying
15M
In Q2 2026
Insider trades, 12 months
2 buys · 40 sales
Net sold $11.05M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| FMR LLC | 71,683,793 | 6.40% | 13G (passive) amendment | Sep 30, 2025 |
| Wellington Management Group LLP | 70,302,416 | 6.40% | 13G (passive) amendment | Mar 31, 2025 |
| Roderick Wong | 69,590,320 | 6.30% | 13G (passive) | Dec 31, 2025 |
| Wellington Investment Advisors Holdings LLP | 67,415,323 | 6.00% | 13G (passive) | Sep 30, 2025 |
| QM11 Limited | 66,329,320 | 5.97% | 13G (passive) amendment | Jun 30, 2025 |
| Chen Yu | 59,130,750 | 5.30% | 13G (passive) | Jun 2, 2026 |
| Rajeev Shah | 57,435,330 | 5.20% | 13G (passive) | Mar 30, 2026 |
| Wellington Management Company LLP | 100,622,628 | 8.20% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ZLAB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rtw Investments, LP | 6,574,032 | 1.53% | $124.91M | – | 1.07% |
| TCG Crossover Management, LLC | 6,137,627 | 1.43% | $116.61M | New | 2.80% |
| Ra Capital Management, L.P. | 5,743,533 | 1.33% | $109.13M | +36,271 | 0.95% |
| ADAR1 Capital Management, LLC | 3,369,034 | 0.78% | $64.01M | +1,943,667 | 2.93% |
| FMR LLC | 2,815,214 | 0.65% | $53.49M | +1,552,823 | 0.00% |
| Goldman Sachs Group Inc | 2,315,480 | 0.54% | $43.99M | +2,204,893 | 0.00% |
| Woodline Partners LP | 2,207,293 | 0.51% | $41.94M | New | 0.13% |
| Frazier Life Sciences Management, L.P. | 1,902,320 | 0.44% | $36.14M | – | 0.79% |
| Bamco Inc /Ny/ | 1,623,694 | 0.38% | $30.85M | −34,624 | 0.05% |
| Two Sigma Investments, LP | 1,299,394 | 0.30% | $24.69M | +989,671 | 0.02% |
| Citadel Advisors LLC | 1,284,706 | 0.30% | $24.41M | −403,926 | 0.00% |
| Rock Springs Capital Management LP | 814,707 | 0.19% | $15.48M | – | 0.76% |
| BlackRock, Inc. | 664,462 | 0.15% | $12.62M | −200,684 | 0.00% |
| C WorldWide Group Holding A/S | 510,000 | 0.12% | $9.69K | – | 0.23% |
| Jane Street Group, LLC | 476,541 | 0.11% | $9.05M | +208,615 | 0.00% |
| B Group, Inc. | 450,646 | 0.10% | $8.56M | – | 4.02% |
| Nantahala Capital Management, LLC | 400,000 | 0.09% | $7.60M | New | 0.13% |
| Schroder Investment Management Group | 393,167 | 0.09% | $7.24M | – | 0.01% |
| Nan Fung Trinity (Hk) Ltd | 346,466 | 0.08% | $6.58M | – | 0.65% |
| abrdn plc | 311,294 | 0.07% | $5.91M | +73,555 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 93 | 43M | 10.1% | 16 / 28 | 29 / 21 | 17M | 2M |
| Q1 2026 | 99 | 28M | 6.6% | 17 / 26 | 43 / 42 | 8M | 9M |
| Q4 2025 | 126 | 29M | 6.7% | 33 / 36 | 40 / 44 | 11M | 17M |
| Q3 2025 | 138 | 35M | 8.2% | 21 / 48 | 46 / 38 | 4M | 11M |
| Q2 2025 | 156 | 43M | 9.9% | 33 / 49 | 59 / 36 | 6M | 20M |
| Q1 2025 | 160 | 56M | 13.1% | 46 / 48 | 46 / 16 | 11M | 11M |
| Q4 2024 | 131 | 56M | 13.1% | 37 / 46 | 35 / 9 | 20M | 9M |
| Q3 2024 | 104 | 45M | 10.6% | 17 / 36 | 33 / 17 | 10M | 5M |
| Q2 2024 | 105 | 41M | 9.5% | 13 / 36 | 39 / 22 | 5M | 4M |
| Q1 2024 | 117 | 42M | 9.7% | 18 / 44 | 33 / 24 | 7M | 6M |
| Q4 2023 | 124 | 42M | 9.7% | 22 / 34 | 44 / 19 | 7M | 5M |
| Q3 2023 | 122 | 39M | 9.2% | 12 / 39 | 54 / 27 | 3M | 7M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ZLAB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Baron Emerging Markets Fund | 1,370,904 | 0.32% | $26.05M | 0.65% | Jun 30, 2026 |
| Strategic Advisers Fidelity Emerging Markets Fund | 738,509 | 0.17% | $13.06M | 0.03% | May 31, 2026 |
| iShares Biotechnology ETF | 633,528 | 0.15% | $12.04M | 0.13% | Jun 30, 2026 |
| Fidelity Growth Company Fund | 332,190 | 0.08% | $5.88M | 0.01% | May 31, 2026 |
| Strategic Advisers Emerging Markets Fund | 204,400 | 0.05% | $3.62M | 0.02% | May 31, 2026 |
| Tema Oncology ETF | 196,972 | 0.05% | $3.48M | 1.98% | May 31, 2026 |
| Fidelity Growth Company K6 Fund | 131,934 | 0.03% | $2.33M | 0.01% | May 31, 2026 |
| ALPS Medical Breakthroughs ETF | 115,031 | 0.03% | $2.03M | 1.26% | May 31, 2026 |
| Baron International Growth Fund | 81,821 | 0.02% | $1.55M | 0.48% | Jun 30, 2026 |
| Virtus Biotech Etf | 79,505 | 0.02% | $1.45M | 1.47% | Jul 31, 2026 |
| Fidelity Series Growth Company Fund | 77,700 | 0.02% | $1.37M | 0.01% | May 31, 2026 |
| Destinations International Equity Fund | 75,566 | 0.02% | $1.34M | 0.06% | May 31, 2026 |
| Dimensional Emerging Markets Core Equity 2 ETF | 26,020 | 0.01% | $475.39K | 0.01% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 23,879 | 0.01% | $422.42K | 0.00% | May 31, 2026 |
| Emerging Markets Core Equity 2 Portfolio | 22,834 | 0.01% | $417.18K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ying Du | Chairperson & CEO, Director | 1,226,224 | 0.28% | Jul 6, 2026 |
| Yajing Chen | Chief Financial Officer | 35,635 | 0.01% | Aug 21, 2026 |
| Frazor Titus Edmondson III | Chief Legal Officer | 30,346 | 0.01% | Jun 29, 2026 |
| Yizhe Wang | Operating Partner | – | – | Jun 8, 2026 |
| Joshua L. Smiley | See Remarks | 117,602 | 0.03% | Apr 8, 2026 |
| Rafael Amado | See Remarks | 57,022 | 0.01% | Apr 8, 2026 |
| William Lis | Director | 41,931 | 0.01% | Aug 13, 2026 |
| Richard Gaynor | Director | 80,737 | 0.02% | Jul 6, 2026 |
| Michel Vounatsos | Director | 72,787 | 0.02% | Jun 22, 2026 |
| Scott W. Morrison | Director | 56,904 | 0.01% | Jun 22, 2026 |
| John D. Diekman | Director | 122,140 | 0.03% | Jun 22, 2026 |
| Leon O. Moulder Jr | Director | 94,973 | 0.02% | Jun 22, 2026 |
| Peter Wirth | Director | 420,121 | 0.10% | Jun 22, 2026 |
| Nisa Leung | Director | 8,019,229 | 1.86% | Jun 22, 2026 |
| Kai-Xian Chen | Director | 39,525 | 0.01% | Jan 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Yajing Chen Chief Financial Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −260 | $27.00 | $7.02K | 35,635 |
| Yajing Chen Chief Financial Officer | Aug 14, 2026 | Tax withholding | −427 | $25.90 | $11.06K | 35,895 |
| Yajing Chen Chief Financial Officer | Aug 14, 2026 | Option exercise | +1,250 | – | – | 36,322 |
| William Lis Director | Aug 12, 2026 | Sale(10b5-1 plan) | −8,506 | $25.00 | $212.65K | 41,931 |
| Yajing Chen Chief Financial Officer | Aug 11, 2026 | Sale(10b5-1 plan) | −619 | $25.00 | $15.48K | 35,072 |
| Ying Du Chairperson & CEO, Director | Jul 2, 2026 | Option exercise | +11,048 | – | – | 1,225,749 |
| Ying Du Chairperson & CEO, Director | Jul 2, 2026 | Tax withholding | −4,348 | $19.12 | $83.13K | 1,221,401 |
| Ying Du Chairperson & CEO, Director | Jul 1, 2026 | Option exercise | +18,000 | – | – | 1,221,784 |
| Ying Du Chairperson & CEO, Director | Jul 1, 2026 | Tax withholding | −7,083 | $19.15 | $135.64K | 1,214,701 |
| Richard Gaynor Director | Jul 1, 2026 | Buy | +1,736 | $19.05 | $33.07K | 80,737 |
| Ying Du Chairperson & CEO, Director | Jun 30, 2026 | Sale | −7,026 | $18.53 | $130.19K | 1,203,784 |
| Ying Du Chairperson & CEO, Director | Jun 29, 2026 | Option exercise | +17,970 | – | – | 1,210,810 |
| Ying Du Chairperson & CEO, Director | Jun 26, 2026 | Sale | −24,543 | $17.46 | $428.52K | 1,192,840 |
| Frazor Titus Edmondson III Chief Legal Officer | Jun 26, 2026 | Sale | −4,103 | $17.46 | $71.64K | 30,346 |
| Yajing Chen Chief Financial Officer | Jun 26, 2026 | Sale | −2,264 | $17.46 | $39.53K | 35,691 |
| Ying Du Chairperson & CEO, Director | Jun 25, 2026 | Option exercise | +58,800 | – | – | 1,217,383 |
| Frazor Titus Edmondson III Chief Legal Officer | Jun 25, 2026 | Option exercise | +14,600 | – | – | 34,449 |
| Yajing Chen Chief Financial Officer | Jun 25, 2026 | Option exercise | +6,250 | – | – | 37,955 |
| William Lis Director | Jun 22, 2026 | Sale(10b5-1 plan) | −7,040 | $18.09 | $127.35K | 50,437 |
| Michel Vounatsos Director | Jun 17, 2026 | Award | +22,371 | – | – | 72,787 |
| Richard Gaynor Director | Jun 17, 2026 | Award | +22,371 | – | – | 79,001 |
| Peter Wirth Director | Jun 17, 2026 | Award | +22,371 | – | – | 416,121 |
| Scott W. Morrison Director | Jun 17, 2026 | Award | +22,371 | – | – | 56,904 |
| William Lis Director | Jun 17, 2026 | Award | +22,371 | – | – | 57,477 |
| Leon O. Moulder Jr Director | Jun 17, 2026 | Award | +22,371 | – | – | 94,973 |
| John D. Diekman Director | Jun 17, 2026 | Award | +22,371 | – | – | 122,140 |
| Nisa Leung Director | Jun 17, 2026 | Award | +22,371 | – | – | 96,297 |
| Ying Du Chairperson & CEO, Director | May 27, 2026 | Gift | −53,850 | – | – | 1,158,583 |
| Ying Du Chairperson & CEO, Director | May 27, 2026 | Gift | −33,993 | – | – | 1,212,433 |
| Ying Du Chairperson & CEO, Director | May 26, 2026 | Gift | −19,857 | – | – | 1,246,426 |
| Ying Du Chairperson & CEO, Director | May 19, 2026 | Option exercise | +261,092 | $1.74 | $454.30K | 1,383,718 |
| Ying Du Chairperson & CEO, Director | May 19, 2026 | Tax withholding | −117,435 | $18.75 | $2.20M | 1,266,283 |
| Ying Du Chairperson & CEO, Director | May 18, 2026 | Sale(10b5-1 plan) | −50,000 | $19.00 | $950.00K | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 18, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Ying Du Chairperson & CEO, Director | May 15, 2026 | Sale(10b5-1 plan) | −50,000 | $20.74 | $1.04M | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 15, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Frazor Titus Edmondson III Chief Legal Officer | May 14, 2026 | Sale(10b5-1 plan) | −3,517 | $20.19 | $71.01K | 19,849 |
| Ying Du Chairperson & CEO, Director | May 14, 2026 | Sale(10b5-1 plan) | −50,000 | $20.09 | $1.00M | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 14, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Ying Du Chairperson & CEO, Director | May 13, 2026 | Sale(10b5-1 plan) | −33,769 | $20.22 | $682.81K | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 13, 2026 | Sale(10b5-1 plan) | −16,231 | $19.44 | $315.53K | 1,156,395 |
| Ying Du Chairperson & CEO, Director | May 13, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Rafael Amado See Remarks | Apr 6, 2026 | Sale | −2,739 | $20.45 | $56.01K | 57,022 |
| Frazor Titus Edmondson III Chief Legal Officer | Apr 6, 2026 | Sale | −1,224 | $20.45 | $25.03K | 23,366 |
| Yajing Chen Chief Financial Officer | Apr 6, 2026 | Sale | −853 | $20.45 | $17.44K | 31,705 |
| Ying Du Chairperson & CEO, Director | Apr 6, 2026 | Sale | −2,653 | $20.45 | $54.25K | 1,122,626 |
| Joshua L. Smiley See Remarks | Apr 6, 2026 | Sale | −3,017 | $20.45 | $61.70K | 117,602 |
| Ying Du Chairperson & CEO, Director | Apr 2, 2026 | Option exercise | +6,750 | – | – | 1,130,855 |
| Ying Du Chairperson & CEO, Director | Apr 2, 2026 | Sale | −5,576 | $20.39 | $113.69K | 1,125,279 |
| Yajing Chen Chief Financial Officer | Apr 2, 2026 | Sale | −5,199 | $20.39 | $106.01K | 32,558 |
| Yajing Chen Chief Financial Officer | Apr 2, 2026 | Option exercise | +2,500 | – | – | 37,757 |
| Frazor Titus Edmondson III Chief Legal Officer | Apr 2, 2026 | Sale | −4,194 | $20.39 | $85.52K | 24,590 |
| Frazor Titus Edmondson III Chief Legal Officer | Apr 2, 2026 | Option exercise | +5,031 | – | – | 28,784 |
| Rafael Amado See Remarks | Apr 2, 2026 | Option exercise | +5,391 | – | – | 69,671 |
| Rafael Amado See Remarks | Apr 2, 2026 | Sale | −9,910 | $20.39 | $202.06K | 59,761 |
| Joshua L. Smiley See Remarks | Apr 2, 2026 | Option exercise | +7,145 | – | – | 130,233 |
| Joshua L. Smiley See Remarks | Apr 2, 2026 | Sale | −9,614 | $20.39 | $196.03K | 120,619 |
| Ying Du Chairperson & CEO, Director | Apr 1, 2026 | Option exercise | +10,800 | – | – | 1,120,705 |
| Ying Du Chairperson & CEO, Director | Apr 1, 2026 | Option exercise | +3,400 | – | – | 1,124,105 |
| Yajing Chen Chief Financial Officer | Apr 1, 2026 | Option exercise | +1,500 | – | – | 21,499 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Joshua L. Smiley Former Officer | Aug 20, 2026 | 98,653 | $2.58M | Aug 20, 2026 | Stock Option Exercise |
| Yajing Chen Officer | Aug 19, 2026 | 260 | $7.02K | Aug 19, 2026 | Restricted Stock Vesting |
| William Lis Director | Aug 12, 2026 | 8,506 | $212.65K | Aug 12, 2026 | Restricted Stock Vesting |
| Yajing Chen Officer | Aug 11, 2026 | 619 | $15.48K | Aug 11, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | Jun 30, 2026 | 7,026 | $130.22K | Jun 30, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | Jun 26, 2026 | 24,543 | $428.55K | Jun 26, 2026 | Restricted Stock Vesting |
| Frazor Titus Edmondson III Officer | Jun 26, 2026 | 4,103 | $71.64K | Jun 26, 2026 | Restricted Stock Vesting |
| Yajing Chen Officer | Jun 26, 2026 | 2,264 | $39.53K | Jun 26, 2026 | Restricted Stock Vesting |
| William Lis Director | Jun 22, 2026 | 7,040 | $127.35K | Jun 22, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | May 18, 2026 | 50,000 | $976.00K | May 18, 2026 | Option Granted - 08/25/2016 |
| Ying Du Officer, Director | May 15, 2026 | 50,000 | $1.02M | May 15, 2026 | Option Granted - 08/25/2016 |
| Frazor Titus Edmondson III Officer | May 14, 2026 | 3,517 | $71.01K | May 14, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | May 14, 2026 | 50,000 | $1.00M | May 14, 2026 | Option Granted - 08/25/2016 |
| Ying Du Officer, Director | May 13, 2026 | 50,000 | $960.00K | May 13, 2026 | Option Granted - 08/25/2016 |
| Joshua L. Smiley Officer | Apr 6, 2026 | 3,017 | $61.69K | Apr 6, 2026 | Restricted Stock Vesting |